Skip to main content
OIDA Image Collection
Filters:
Reset 
A slide from a presentation about Kinexra (Bryostamin) H2O injection. The slide has a blue background with white text. On the left side of the slide there is a close-up of a white control button with the word "control" written on it. The text on the slide explains that the treatment is to preserve memory and cognition for as long as possible. On the right side there are three bullet points that explain the benefits of the treatment. The first bullet point explains that helps reduce caregiver burden and improves caregiver quality of life. The second bullet point mentions that in dose and time dependent studies Kinexa showed a very high level of effectiveness in alpha-secrets assay which appears to reflect the powerful activation of PKC-delta and epsilon. The third bullet point discusses using the adds-cog scale 60 percent of treated patients maintained or improved performance over a 12 month period compared to 40% of patients on placebo. The slide also mentions that KineXra has been shown to be safe with other oral agents including accept and named.

Description Generated using AI

A slide from a presentation about Kinexra (Bryostamin) H2O injection. The slide has a blue background with white text. On the left side of the slide there is a close-up of a white control button with the word "control" written on it. The text on the slide explains that the treatment is to preserve memory and cognition for as long as possible. On the right side there are three bullet points that explain the benefits of the treatment. The first bullet point explains that helps reduce caregiver burden and improves caregiver quality of life. The second bullet point mentions that in dose and time dependent studies Kinexa showed a very high level of effectiveness in alpha-secrets assay which appears to reflect the powerful activation of PKC-delta and epsilon. The third bullet point discusses using the adds-cog scale 60 percent of treated patients maintained or improved performance over a 12 month period compared to 40% of patients on placebo. The slide also mentions that KineXra has been shown to be safe with other oral agents including accept and named.

Type Generated using AI

Category

We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.

Cite This Image

Information copied to your clipboard:

"A slide from a presentation about Kinexra (Bryostamin) H2O injection. The slide has a blue background with white text. On the left side of the slide ...